CompletedPhase 2ketamine

Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

Sponsored by Javelin Pharmaceuticals

NCT ID
NCT00488787
Target Enrollment
40 participants
Start Date
2001-03
Est. Completion
2001-04

About This Study

Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.

Conditions Studied

Pain, Postoperative

Interventions

  • intranasal ketamine
  • intranasal ketamine
  • intranasal ketamine
  • placebo

Eligibility

Age:16 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Healthy patients at least 16 years of age requiring two or more third molar extractions

Exclusion Criteria:

* Less than 16 years old
* Other exclusion criteria may apply

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source